Explore
Trendline
Prothena Corporation Announces Leadership Changes to Drive Growth Strategy
Prothena Corporation Announces Leadership Changes to Drive Growth Strategy
Read More
Trendline
Avalyn Pharma Files for IPO to Fund Respiratory Disease Treatments
Avalyn Pharma Files for IPO to Fund Respiratory Disease Treatments
Read More
Trendline
Longevity Health and Spyglass Pharma: A Comparative Analysis of Small-Cap Biotech Firms
Longevity Health and Spyglass Pharma: A Comparative Analysis of Small-Cap Biotech Firms
Read More
Trendline
Prothena Corporation Announces Key Leadership Changes to Drive Strategic Growth
Prothena Corporation Announces Key Leadership Changes to Drive Strategic Growth
Read More
Trendline
Prothena Corporation Announces Leadership Changes to Drive Strategic Growth
Prothena Corporation Announces Leadership Changes to Drive Strategic Growth
Read More
Trendline
Prothena Corporation Announces Leadership Team Changes to Drive Strategic Growth
Prothena Corporation Announces Leadership Team Changes to Drive Strategic Growth
Read More
Trendline
Byondis Appoints Christoph Korpus as CEO to Advance Antibody-Drug Conjugate Technology
Byondis Appoints Christoph Korpus as CEO to Advance Antibody-Drug Conjugate Technology
Read More
Trendline
Byondis Appoints Christoph Korpus as CEO to Drive Strategic Growth
Byondis Appoints Christoph Korpus as CEO to Drive Strategic Growth
Read More
Trendline
ZYUS Life Sciences Updates on Non-Opioid Drug Development Amid Financial Challenges
ZYUS Life Sciences Updates on Non-Opioid Drug Development Amid Financial Challenges
Read More
Trendline
Roche Invests $1 Billion in C4T's Degrader-Antibody Conjugates
Roche Invests $1 Billion in C4T's Degrader-Antibody Conjugates
Read More
Trendline
Tempus and Gilead Sciences Expand Collaboration to Enhance Oncology Research with AI Insights
Tempus and Gilead Sciences Expand Collaboration to Enhance Oncology Research with AI Insights
Read More
Trendline
Emalex Biosciences Secures Patent for Innovative Tourette Syndrome Treatment
Emalex Biosciences Secures Patent for Innovative Tourette Syndrome Treatment
Read More
